Welcome to our dedicated page for HEALTHPEAK PROPERTIES SEC filings (Ticker: DOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthpeak Properties, Inc. filings document the regulatory record of a Maryland REIT focused on healthcare discovery and delivery real estate. Form 8-K reports furnish quarterly and annual financial results, supplemental operating information, Regulation FD materials, non-GAAP reconciliations, and material agreements tied to credit facilities and other financing activity.
Proxy and annual-meeting filings describe board elections, shareholder voting results, executive compensation, and governance matters. The filing record also covers capital-structure disclosures for Healthpeak and Healthpeak OP, including unsecured term loan amendments, delayed-draw financing, senior notes, and related subsidiary financing activity.
State Street Corporation reported beneficial ownership of common stock of Healthpeak Properties, Inc.. The filing states that State Street beneficially owns 44,044,096 shares of Healthpeak common stock, representing 6.4% of the class.
State Street reports no sole voting or dispositive power over these shares. It has shared voting power over 31,852,989 shares and shared dispositive power over 44,007,417 shares, primarily through asset management subsidiaries such as State Street Global Advisors entities. The ownership is not reported on behalf of any other person entitled to more than 5% of the class, and no shareholder group arrangements are disclosed.
Healthpeak Properties, Inc. reported total revenues of $771,579 thousand for the quarter and $1,524,531 thousand for the six months ended June 30, 2026. Net income attributable to Healthpeak was $52,818 thousand for the quarter and $246,451 thousand year-to-date, equal to basic and diluted earnings per common share of $0.08 and $0.36, respectively.
Total assets were $21,680,046 thousand and total equity $9,470,745 thousand at June 30, 2026. The company completed the Janus Living, Inc. IPO and June follow-on offerings, raising gross proceeds of $966 million and $719 million, and retained voting and economic rights to 73.6% of Janus Living. It acquired additional senior housing assets, bought out partners in the SWF senior housing JV and Gateway Crossing JV, and sold various lab and outpatient medical properties. In July 2026 it formed a Brookfield joint venture for 86 outpatient medical buildings at a gross valuation of approximately $2.1 billion, generating about $1.025 billion of proceeds, while remaining asset manager. Cash, cash equivalents, and restricted cash rose to $1,718,685 thousand, supported by $621,981 thousand of net operating cash flow and active use of the $2,000,000 thousand Commercial Paper Program.
Healthpeak Properties reported solid second-quarter 2026 results, with net income applicable to common shares of $52.7 million, or $0.08 per diluted share, up from $0.05 a year earlier. Total revenues were $771,579 thousand, and diluted FFO as Adjusted remained $0.46 per share. Same-store Adjusted NOI grew 1.8% overall, driven by a 19.2% increase in Senior Housing, partially offset by a 3.2% decline in Lab. Subsidiary Janus Living delivered strong growth, with Q2 revenue of $216 million and Adjusted EBITDAre of $79 million, up 45% and 34% year over year, respectively.
Capital recycling and balance sheet actions were significant. Healthpeak generated $1.4 billion of proceeds in Q2 and through August 3, including about $1.025 billion from selling a 49% interest in an 86-asset outpatient portfolio to Brookfield at a 5.9% cap rate, plus a $400 million seller-financing repayment and $40 million of dispositions. Net Debt to Adjusted EBITDAre was 4.7x, and liquidity totaled $3.4 billion. The company repurchased 5.9 million shares for roughly $100 million, authorized a new $500 million buyback, and declared monthly dividends of $0.10167 per share for July–September, annualizing to $1.22. Full-year 2026 guidance was raised, with diluted EPS now targeted at $0.48–$0.52 and diluted FFO as Adjusted at $1.73–$1.77 per share.
JPMorgan Chase & Co. filed an amended Schedule 13G reporting its beneficial ownership in Healthpeak Properties, Inc. common stock. JPMorgan reports beneficial ownership of 29,934,020 shares of common stock, representing 4.3% of the class.
The filing breaks down this position into 17,715,724 shares with sole voting power and 11,377,964 shares with shared voting power. JPMorgan also reports 18,546,974 shares with sole dispositive power and 11,381,545 shares with shared dispositive power. The position is reported as ownership of 5 percent or less of the class.
HEALTHPEAK PROPERTIES, INC. director Thomas John T reported routine equity compensation activity. On May 29, 2026, he acquired 1,385 shares of Common Stock at $15.4615 per share, with a footnote stating these shares were purchased via the issuer's Employee Stock Purchase Plan. In connection with this acquisition, 78 shares at $19.15 per share were forfeited to satisfy tax withholding obligations, which the filing notes does not constitute a sale. Following these transactions, he holds 829,975 shares directly and 58 shares indirectly held "By Child 7."
HEALTHPEAK PROPERTIES, INC. executive Ankit B. Patadia reported routine equity compensation activity involving the company’s Employee Stock Purchase Plan. He acquired 1,358 shares of common stock, noted at a price of $15.4615 per share, through the ESPP. In connection with this acquisition, 94 shares were forfeited to satisfy applicable tax withholding obligations at a value of $19.15 per share; the footnotes clarify that this forfeiture does not constitute a sale transaction. Following these transactions, he directly holds 8,953 shares of common stock.
HEALTHPEAK PROPERTIES, INC. Chief Financial Officer Kelvin O. Moses reported common stock activity tied to the company’s Employee Stock Purchase Plan on May 29, 2026. He acquired 937 shares at $15.4615 per share, while 65 shares were forfeited to satisfy tax withholding obligations rather than sold. After these transactions, he holds 1,627 shares of common stock directly.
HEALTHPEAK PROPERTIES, INC. CIO Adam G. Mabry reported routine equity compensation activity. On May 29, 2026 he acquired 625 shares of Common Stock through the company’s Employee Stock Purchase Plan at $15.4615 per share. In connection with this ESPP purchase, 43 shares were forfeited to satisfy tax withholding obligations, which is not treated as an open-market sale. Following these transactions, he directly holds 5,097 shares of Common Stock.
HEALTHPEAK PROPERTIES EVP and CAO Shawn G. Johnston acquired 1,358 shares of Common Stock through the company’s Employee Stock Purchase Plan. In a related move, 76 shares were forfeited to cover tax withholding obligations, which the disclosure states does not constitute a sale. Following these transactions, Johnston directly holds 42,260 shares of Common Stock.
HEALTHPEAK PROPERTIES, INC. President and CEO Scott M. Brinker reported routine equity activity involving the company’s Common Stock. He acquired 1,347 shares on May 29, 2026 at an average price of $15.4615 per share through the company’s Employee Stock Purchase Plan (ESPP).
On the same date, 114 shares were forfeited at $19.15 per share to satisfy applicable tax withholding obligations. The footnotes state this forfeiture does not constitute a sale transaction. After these transactions, Brinker directly owned 214,688 shares of Common Stock.